0001246360-14-003019.txt : 20140626
0001246360-14-003019.hdr.sgml : 20140626
20140619172809
ACCESSION NUMBER: 0001246360-14-003019
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140617
FILED AS OF DATE: 20140619
DATE AS OF CHANGE: 20140619
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SYNAGEVA BIOPHARMA CORP
CENTRAL INDEX KEY: 0000911326
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 561808663
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 33 HAYDEN AVE.
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: (781) 357-9900
MAIL ADDRESS:
STREET 1: 33 HAYDEN AVE.
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: TRIMERIS INC
DATE OF NAME CHANGE: 19970516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Quart Barry D
CENTRAL INDEX KEY: 0001384243
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23155
FILM NUMBER: 14931112
MAIL ADDRESS:
STREET 1: C/O INTRABIOTICS PHARMACEUTICALS INC
STREET 2: 1009 OAK HILL ROAD, SUITE 201
CITY: LAFAYETTE
STATE: CA
ZIP: 94549
4
1
form.xml
PRIMARY DOCUMENT
X0306
4
2014-06-17
false
0000911326
SYNAGEVA BIOPHARMA CORP
GEVA
0001384243
Quart Barry D
33 HAYDEN AVE
LEXINGTON
MA
02421
true
false
false
false
Common Stock
2014-06-17
4
M
false
1000
23.95
A
1000
D
Common Stock
2014-06-17
4
S
false
1000
90
D
0
D
Stock Option (Right to Buy)
23.95
2014-06-17
4
M
false
1000
0
D
2017-06-27
Common Stock
1000
1000
D
The stock option exercise and sale of shares of common stock ("Shares") reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 10, 2014.
The reporting person previously transferred an option to purchase 2,000 Shares of the original 4,000 granted under this stock option, which transfer was not previously reported as permitted under Rule 16a-12 of the Securities Exchange Act.
The stock option granted the reporting person an option to purchase 4,000 Shares. These options vested one-third every year over a three-year period and became exercisable on the following schedule: 33.33% on June 27, 2008, 33.33% on June 27, 2009, 33.33% on June 27, 2010.
/s/ Thomas W. Beetham, Attorney-in-Fact
2014-06-19